(I125) low-dose rate brachytherapy in localized prostate cancer. Preliminary results of 5 years;Braquiterapia de baja tasa (I125) en el cáncer de próstata localizado. Resultados preliminares a 5 años

Archivos Espanoles de Urologia

Volumn 58, Issue 3, 2005, Pages 213-226

  Prada, Pedro J ^a   Hevia, Miguel ^a   Juan, Germán ^a   Abascal, José M ^a   De La Rúa, Ángeles ^a   Abascal, Ramón ^a   Fernández, Jose ^a   Rodríguez, Reinerio ^a   Iglesias Prieto, Jose Ignacio ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Clinica La Luz   (Spain)

Author keywords

Brachytherapy; Complications; I125; Prostatic cancer; Results

Indexed keywords

RADIOACTIVE IODINE;

ADENOCARCINOMA; AGED; BRACHYTHERAPY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PROSTATE TUMOR; RADIATION DOSE; REVIEW; TIME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 20544443236     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. POLLACK, A.; ZAGARS, G.; SMITH, L.G. y cols.: "Prelimnary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer". J. Clin. Oncol., 23: 3904, 2000.
2. HANKS, G.E.; HANLON, A.L.; PINOVER, W.H. y cols.: "Dose selection for prostate cancer patients based on dose comparison and dose response studies". Int. J. Radiat. Oncol. Bio. Phys., 46: 823, 2000.
3. PRADA, P.J.; ALONSO, A.; CANTELI, M. y cols.: "Resultados del tratamiento con radioterapia externa en el cancer de prostata". Arch. Esp. Urol., 51, 9: 890, 1998.
4. PRADA, P.J.; CANTELI, M.; ALONSO, R. y cols.: "Resultados de la braquiterapia en el Cancer de prostata". Arch. Esp. Urol., 52, 1: 32, 1999.
5. HERMANK, P.; HUTTER, R.V.P.; SOBIN, L.H. y cols.: "TNM atlas. Illustrated Guide to the TNM/pTNM classification of malignant tumours". 4th ed. 1997.
6. PRADA, P.J.; HEVIA, M.; JUAN, G.: "Braquiterapia prostática con implantes permanentes. Técnica de planificación intraoperatoria en tiempo real por cálculo dinámico. Curso de adiestramiento en Braquiterapiá. LXIX Congreso Nacional de Urología. Oviedo. Junio, 2004.
7. American Society for Therapeutic Radiology and Oncology Consensus Panel.: ́Consensus statement: Guidelines for PSA following radiation therapý. Int. J. Radiation Oncology Biol. Phys., 37: 31, 1997.
8. SPSS. Versión 11.5
9. LAWTON, C.A.; WON, M.; PILEPICH, M.V. y cols.: ́Long-term treatment sequelae following external beam irradiation for adenocarcinoma of prostate: analysis of RTOG studies 7506 and 7706́. Int. J. Radiat. Oncol. Biol. Phys., 21: 935, 1991.
10. SUBIR, N.; LAY, P.; CORMACK, R. y cols.: ́Intraoperative planning and evaluation of permanent prostate brachytherapy: Report of the American Brachytherapy Societý. Int. J. Radiat. Oncol. Biol. Phys., 51: 1422, 2001.
11. 3. Dosimetric analysis of implant qualitý. Int. J. Radiat. Oncol. Biol. Phys., 46:1199, 2000.
12. MERRICK, G.S.; WALLNER, K.E.; BUTLER, W.M.: ́Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland". Journal of Urology., Vol. 169: 1643, 2003.
13. WALLNER, K.; LEE, H.; WASSERMAN, S. y cols.: "Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral resection of the prostate". Int. J. Radiat. Oncol. Biol. Phys., 37: 565, 1997.
14. DAVIS, B.J.; PISANSKY, T.M.; WILSON, T.M. y cols.: "The radial distance of extra-prostatic extension of prostate carcinoma: implications for prostate brachytherapy". Cancer, 85: 2630, 1999.
15. NAG, S.; BEYER, D.; FRIEDLAND, J.; GRIMA, P. y cols.: "American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate Cancer". Int. J. Radiat. Oncol. Biol. Phys., Vol. 44, No 4, pp.789, 1999.
16. CARTER, H.B.; EPSTEIN, J.; PARTIN, A.W.: "Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with non-palpable disease". Urology, 53: 126, 1999.
17. HEROLD, D.M.; HANLON, A.L.; MOVSA, B. y cols.: "Age-related prostate cancer metastases". Urology, 51: 985, 1998.
18. MERRICK, G.S.; BUTLER, W.M.; LIEF, J.H. y cols.: "Five-year biochemical outcome after prostate brachytherapy for hormone-naive men ≤ 62 years of age". Int. J. Radiat. Oncol. Biol. Phys., 50: 1253, 2001.
19. STONE, N.S.; STOCK, R.G.: "10-Year biochemical and local control following real-time 1-125 prostate brachytherapy". Journal of Urology, 169, No. 4, supplement, 2003.
20. STOCK, R.G.; STOVE, M.N.; DEKLYNGOERT, J.K. y cols.: "Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma". Cancer, 77: 2386, 1996.
21. STOCK, R.G.; STONE, M.N.; DEWYNGOERT, J.R.: "PSA findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate cancer". Proceedings of the American Radium Society 78th Annual Meeting, Paris, France, p58, 1995.
22. BEYER, D.C.: "Impact of PSA failure on overall and cancer specific survival following permanent prostate brachytherapy". Brachytherapy, 2: 46, 2003.
23. BEYER, D.C.; PRIESTLEY, J.B.: "Biochemical disease-free survival following 1251 prostate implantation". Int. J. Radiat. Oncol. Biol. Phys., 37:559, 1997.
24. BEYER, D.C.: "Permanent prostate brachytherapy the Arizona experience". Radiotherapy and Oncology, 55: 13, 2000.
25. BLASKO, J.C.; GRIMM, J.E.; SYLSVESTER, J.E. y cols.: "The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma". Radiotherapy and Oncology, 57: 273, 2000.
26. RAGDE, H.; GRADO, G.L.; NADIR, B.S.: "Brachytherapy for clinically localized prostate cancer: Thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone". Arch. Esp. Urol., 54, 7: 739, 2001.
27. RAGDE, H.; BLASKO, J.C.; GRIMM, P.D. y cols.: "Brachyterapy for clinically localized prostate cancer: results at 7 and 8 year follow-up". Semin. Surg. Oncol., 13: 438, 1997.
28. RAGDE, H.; ELGAMAL, A.A.; SNOW, P.B. y cols.: "Ten-year disease free survival alter transperineal sonography-guided iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma". Cancer, 83: 989, 1998.
29. RAGDE, H.; KORB, L.: "Brachytherapy for clinically localized prostate cancer". Seminars in Radiation Oncology, 18: 45, 2000.
30. PRESTIDGE, B.R.; HOAK, D.C.; GRIMM, P.D. y cols.: "Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer". J. Radiat. Oncol. Biol. Phys., 37: 1035, 1997.
31. WALLNER, K.; ROY, J.; HARRISON, L.: "Tumor control and morbidity following transperineal iodine 125 implatation for stage T1/T2 prostatic carcinoma". J. Clin. Oncol., 14: 449, 1999.
32. GRADO, G.L.; LARSON, T.R.; BALCH, C.S. y cols.: "Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance". Int. J. Radiat. Oncol. Biol. Phys., 42: 289, 1998.
33. POTTERS, L.; CHA, C.; OSHINSKY, G. Y cols.: "Risk profiles to predict PSA relapse free suvival for patients undergoing permanent prostate brachytherapy". Cancer J. Sci. Am., 5: 301, 1999.
34. ZELEFSKY, M.J.; HOLLISTER, T.; RABEN, A. y cols.: "Five-year biochemical outcome and toxicity with transperineal CT-planned permanent 1-125 prostate implantation for patients with localized prostate cancer". Int. J. Radiat. Oncol. Biol. Phys., 47: 1261, 2000.
35. CRITZ, F.A.; WILLIAMS, W.H.; HOLLADAY, C.T, y cols.: "Post-treatment PSA ≤ 0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniques". Urology, 54: 968, 1999.
36. DATTOLI, M.; WALLNER, K.; SORACE, R. y cols.: "103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma". Int. J. Radiat. Oncol. Biol. Phys., 35: 875, 1996.
37. SHARKEY, J.; CHOVNICK, S.D.; BEHAR, R.J. y cols.: "Outpatient ultrasound-guided palladium 103 brachytherapy for localized adenocarcinoma of the prostate: a preliminary report of 434 patients". Urology, 51: 796, 1998.
38. BATTERMANN, J.J.; BOON, T.A.; MOERLAND, M.A.: "Results of permanent prostate brachytherapy 13 years of experience at a single institution". Radiotherapy and Oncology, 71: 23, 2003.
39. 125I implantation for localized prostate cancer: the Utrecht University experience". Radiotherapy and Oncology, 57: 269, 2000.
40. ASH, D.V.: "Management of localized carcinoma of the prostate: brachytherapy revisited". Clinical Oncology, 9: 219, 1997.
41. FREEDLAND, S.J.; PARTIN, A.W.; EPSTEIN, J.I. y cols.: "Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b". Cancer, 15, 100: 1646, 2004.
42. KHAN, M.A.; HAN, M.; PARTIN, A.W. y cols.: "Long-term cancer control of radical prostatectomy in men younger than 50 years of age". Urology, 62: 86, 2003.
43. HAN, M.; PARTIN, A.W.; ZAHURAK, M. y cols.: "Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer". J. Urol., 169: 517, 2003.
44. HAN, M.; PARTIN, A.W.; POUND, C.R. y cols.: "Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience 806". Urol. Clin. North Am., 28: 555, 2001.
45. HULL, G.W.; RABBANI, F.; ABBAS, F. y cols.: "Cancer control with radical prostatectomy alone in 1,000 consecutive patients". J. Urol., 167: 528, 2002.
46. ROEHL, K.A.; HAN, M.; RAMOS, G.G. y cols.: "Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results 50". J. Urol., 172: 910. 2004.
47. CATALONA, W.J.; SMITH, D.S.: "5-Year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer". Journal of Urology, 152: 1837, 1994.
48. ZUDAIRE, J.J.; MARTIN-MARQUINA, A.; SANCHEZ, D. y cols.: "Prostatectomia radical en adenocarcinoma de próstata clínicamente localizado. Factores influyentes en la supervivencia libre de progresión bioquímica". Actas Urol. Esp., 23: 333, 1999.
49. RIOJA SANZ, L.A.; LIEDANA, J.M.; RONCALES, A. y cols.: "Análisis de una serie de prostatectomias radicales". Actas Urol. Esp., 21: 809, 1997.
50. TRUAN, D.; CARRETERO, P.; ALCOVER, J.: "Prostatectomia radical". Hospital Clinic Barcelona. Datos no publicados. 2004.
51. ALEXIANU, M.; WEISS, G.H.: "Radical prostatectomy versus brachytherapy for early-stage prostate cancer". Journal Endourology, 14: 325, 2000.
52. 125Iodine brachytherapy for localized prostate cancer". Journal of Urology, 161: 1212, 1999.
53. POLASCIK, T.J.; POUND, C.R.; DEWEESE, T.L. y cols.: "Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis". Urology, 51: 884, 1998.
54. D'AMICO, A.; WHITTINGTON, R.; MALKOWICZ, B. y cols.: "Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer". JAMA, 280: 969, 1998.
55. KUPELIAN, P.A.; POTTERS, L.; KHUNTIA, D. y cols.: "Radical prostatectomy, external beam radiotherapy <72Gy, external beam radiotherapy ≥ 72Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer". Int. J. Radiat. Oncol. Biol. Phys., 58: 25, 2004.
56. POTTERS, L.; KLEIN, E.A.; KATTAN, M.W. y cols.: "Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation". Radiother. Oncol., 71: 29, 2004.
57. STONE, N.N.: "Brachytherapy or radical prostatectomy: is there a preferred method for treating localized prostate cancer?". BJU Int., 93: 5, 2004.
58. BLASKO, J.C.; RADGE, H.; GRIMM, P.D.: "Transperineal ultrasound-guided implantation of the prostate: Morbility and complications". Scand J. Urol. Nephrol. Suppl., 137: 113, 1991.
59. WALSH, P.C.; PARTIN, A.W.; EPSTEIN, J.I.: "Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years". Journal of Urology, 152:1831, 1994.
60. CATALONA, W.J.: "Surgical management of prostate cancer. Contemporary results with anatomic radical prostatectomy". Cancer, 75: 1903, 1995.
61. CATALONA, W.J.; CARVALHAL, G.F.; MAGER, D.E. y cols.: "Potency, continence and complication rates in 1.870 consecutive radical retropubic prostatectomies". Journal of Urology, 162:433, 1999.
62. VALDIVIA, P.; GONZALVO, A.; BLAS MARIN, M. y cols.: "Calidad de vida tras prostatectomia radical". Actas Urol. Esp., 21: 903, 1997.
63. MARTIN-MARQUINA, A.; ZUDAIRE, J.J.; SANCHEZ, D. y cols.: "Prostatectomia radical complicaciones quirúrgicas". Actas Urol. Esp., 23: 5, 1999.
64. ALCOCER, J.: "Papel de la cirugía y de la radioterapia en el tratamiento multidisciplinar del cancer de próstata no metastático. Efectos secundarios de la cirugía radical". Encuentros médicos. Barcelona. 1999.
65. BLASCO, J.C.; RADGE, H.; LUSE, R.W. y cols.: "Should brachytherapy be considered a therapeutic option in localized prstate cancer?". Urol. Clin. North Am., 23: 633, 1996.
66. STOCK, R.G.; STONE, M.N.; IANUZZIC.: "Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer". Int. J. Radiat. Oncol. Biol. Phys., 35: 267, 1996.
67. STONE, M.N.; RATNOW, E.R.; STOCK, R.G.: "Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation". Techniques in Urology, 6:123, 2000.
68. BATTERMANN, J.J.; VAN ES C.A.: "The learning curve in prostate seed implantation". Cancer/radiother., 4: 119, 2000.
69. AL-BOOZ, H.; ASH, D.V.; BOTTOMLEY, D.M. y cols.: B.J.U. international, 83: 53, 1999.
70. GELBLUM, D.Y.; POTTERS, L.; ASHLEY, R. y cols.: "Urinary morbidity following ultrasound-guided transperineal prostate seed implantation". Int. J. Radiat. Oncol. Biol. Phys., 45: 59, 1999.
71. GELBLUM, D.Y.; POTTERS, L.: "Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer". Int. J. Radiat. Oncol. Biol. Phys., 48: 119, 2000.
72. PRADA, P.J.: "Efectos agudos y crónicos de la braquiterapia. Curso Internacional sobre diagnóstico precoz del cáncer de próstata. Manejo de la enfermedad órgano confinada, supervivencia y morbilidad". Comunicación personal. Madrid, Noviembre, 2004.
73. PRADA, P.J.; JUAN, G.; HEVIA, M. y cols.: 'Técnica de planificación intraoperatoria en braquiterapia prostática con implantes permanentes de 1251 ó 103Pd". Arch. Esp. Urol., 55: 1217, 2002.
74. PRADA, P.J.: "Braquiterapia como tratamiento curativo en el cancer de próstata". Encuentros Médicos. Madrid; 2004.
75. HUDSON, R.: "Brachytherapy treatments increasing among Medicare population." Health Policy Brief of the American Urological Association, inc., 9:1, 1999.
76. LANGLEY, S.E.M.; LAING, R.: "Prostate brachytherapy has come of age: a review of technique and results". B.J.U. international, 89: 241, 2001.